
In today’s briefing:
- An Update of Our 2025 High Conviction Pick: Samsung Electronics
- Hanwha Ocean: Negative Impact from Chinese Government’s Efforts to Crack Down on U.S. Subsidiaries
- Paypal & Google Are Quietly Launching The Future Of Commerce—Your Wallet Just Got Smarter!
- TCS’s $7 Billion Bet: Building India’s AI Backbone
- Mosaic Crashes On Plant Woes — But One Fix Could Spark A Big Rebound!
- Japanese Banks – We Clip Our Key Positive Picks in the Big-Caps and Mid-Caps
- Memory Monitor: Nanya Tech Indicates DRAM Price Spike to Persist Longer; SK Hynix Relative Trade
- Primer: Peel Hunt Ltd/Guernsey (PEEL LN) – Oct 2025
- Microsoft’s New AI Can Give Health Advice—And Harvard Is Backing It!
- J&J’s Pursuit of Protagonist Therapeutics: A Strategic Move To Reinforce Immunology Leadership Post-Stelara!

An Update of Our 2025 High Conviction Pick: Samsung Electronics
- Back on 6 November 2024, we published an insight called 2025 High Conviction: Samsung Electronics. In this insight, we provide an update of Samsung Electronics.
- Samsung Electronics reported operating profit of 12.1 trillion won (up 31.8% YoY and 18.7% higher than consensus) in 3Q 2025.
- The final installment of the 12 trillion won+ inheritance tax is due in April 2026.
Hanwha Ocean: Negative Impact from Chinese Government’s Efforts to Crack Down on U.S. Subsidiaries
- Chinese government’s efforts to ban Hanwha Ocean’s five U.S. subsidiaries from conducting any transactions with organizations or individuals in China is likely to have material Negative impact on Hanwha Ocean.
- If Hanwha’s U.S. subsidiaries are banned from Chinese suppliers, they’ll need to source alternatives (Japan, Europe, or domestic U.S. firms), that could involve 20–50% higher costs with longer lead times.
- Basically, what’s going on is that the Chinese government wants to slow down the United States’ efforts to rebuild its shipbuilding sector with the help of Korean shipbuilders.
Paypal & Google Are Quietly Launching The Future Of Commerce—Your Wallet Just Got Smarter!
- The commerce landscape is about to undergo a structural transformation as PayPal and Alphabet’s Google join forces in a multi-pronged AI-driven payments partnership launching in Q4 2025.
- Announced in September, the alliance will embed PayPal’s checkout experience directly into Google’s ecosystem—across Google Cloud, Google Ads, Google Play, and select consumer-facing properties.
- At the same time, the two companies are co-developing AI frameworks to power agent-led transactions, where autonomous digital agents make purchases on a user’s behalf using PayPal data.
TCS’s $7 Billion Bet: Building India’s AI Backbone
- Tata Consultancy Services has announced a bold USD 6–7 billion investment to build a 1 GW sovereign AI data center network across India, its most capital-intensive project to date.
- This move shifts TCS from labor-based IT services to AI-driven infrastructure, aligning it with global compute leaders and advancing India’s AI and data-sovereignty goals.
- TCS’s initiative could reshape India’s digital backbone, driving investment across allied sectors and marking a long-term re-rating opportunity for Indian tech toward infrastructure-led growth.
Mosaic Crashes On Plant Woes — But One Fix Could Spark A Big Rebound!
- Shares of fertilizer giant Mosaic Co. have been under significant pressure as the company grapples with dual setbacks — unplanned phosphate plant outages and ongoing macroeconomic headwinds tied to U.S. trade tariffs.
- On October 10, the company disclosed a meaningful production shortfall in its phosphate segment for Q3 2025, citing mechanical issues and utility interruptions that pushed preliminary volumes down to just 1.7 million tons, well below expectations.
- This comes on top of a challenging landscape in which U.S. tariffs have eroded the competitiveness of American fertilizer exports.
Japanese Banks – We Clip Our Key Positive Picks in the Big-Caps and Mid-Caps
- Along with political turbulence, expectations of a near term BoJ rate hike may be diminishing; nonetheless, we believe that these rate hikes will, at worst, be delayed and not derailed
- We take profits on Mizuho in big caps and on Hirogin Holdings in mid-caps, downgrading these names from buy to neutral whilst generally retaining banks with higher levels of cross-holdings
- We maintain the following Japanese banks on buy ratings; in the big-caps, we keep Resona and Shizuoka and in the mid-caps we stick with Iyogin Holdings, Hokuhoku and Hachijuni
Memory Monitor: Nanya Tech Indicates DRAM Price Spike to Persist Longer; SK Hynix Relative Trade
- Nanya Tech 3Q25: Rebounds to Profit Thanks to DDR4 Price Surge Windfall… But Underlying Structural Drivers Remain Unsteady
- The World’s DDR4 Shortage to Extends Pricing Spike Through 4Q25
- Nanya Technology vs SK Hynix — We Expect Relative Strength Ahead for SK Hynix Over Nanya Tech
Primer: Peel Hunt Ltd/Guernsey (PEEL LN) – Oct 2025
- Peel Hunt is a UK-based investment bank specializing in mid-cap and growth companies, offering a diversified suite of services across investment banking, research and distribution, and execution services. This integrated model provides some resilience against market cyclicality.
- The company’s financial performance has been impacted by challenging UK capital market conditions, characterized by a downturn in IPOs and M&A activity. This has led to recent net losses and a declining revenue trend over the past three years.
- Management is focused on strategic initiatives to drive future growth, including expanding its client base, particularly within the FTSE 350, diversifying revenue streams with a greater emphasis on M&A advisory, and investing in technology to enhance efficiency and client offerings.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
Microsoft’s New AI Can Give Health Advice—And Harvard Is Backing It!
- Microsoft is making a bold move into the healthcare AI space, partnering with Harvard Medical School to improve the reliability of medical advice generated by its Copilot assistant.
- The collaboration, set to be unveiled with an update to Copilot as early as this month, integrates health content from Harvard Health Publishing.
- This step reflects Microsoft’s broader ambitions to establish Copilot as a leading AI assistant not just in productivity software but in areas demanding high accuracy and trust—like healthcare.
J&J’s Pursuit of Protagonist Therapeutics: A Strategic Move To Reinforce Immunology Leadership Post-Stelara!
- As Johnson & Johnson (JNJ) faces intensifying competition in the immunology landscape, recent reports indicate the healthcare behemoth is exploring the acquisition of Protagonist Therapeutics, a biotechnology firm currently collaborating with JNJ on the development of icotrokinra, a novel oral therapy targeting immune diseases like plaque psoriasis and ulcerative colitis.
- The news has driven Protagonist’s stock up nearly 30%, valuing the company at around $4.2 billion.
- JNJ already holds exclusive commercialization rights to icotrokinra, which analysts at Leerink Partners project could generate peak global sales of $9.5 billion.